Azenta Genewiz is a biotechnology company that specializes in genetic testing, providing a range of services to help individuals and healthcare professionals make informed decisions about their health. With a focus on innovation and accuracy, Azenta Genewiz has become a trusted name in the field of genetic testing.

One of the key areas of focus for Azenta Genewiz is cancer testing. By analyzing a patient’s genetic makeup, Azenta Genewiz can identify potential cancer risks and provide personalized recommendations for prevention and treatment. This can be especially valuable for individuals with a family history of cancer or those who have already been diagnosed.

In addition to cancer testing, Azenta Genewiz also offers a range of other genetic testing services, including carrier screening, pharmacogenomics, and whole exome sequencing. With a commitment to quality and accuracy, Azenta Genewiz is dedicated to helping individuals and healthcare professionals make informed decisions about their health.

History of Azenta Genewiz

I have researched the history of Azenta Genewiz, a leading biotech life sciences company. Azenta Genewiz was founded in 1999 by Dr. Steve Sun and Dr. Ruiqiang Li. The company was originally based in South Plainfield, New Jersey, but has since expanded its operations to several other locations across the United States and around the world.

Azenta Genewiz started as a small biotech company specializing in DNA sequencing and genotyping services. Over the years, the company has grown and diversified its offerings to include a wide range of genomic services, including gene expression analysis, epigenetic analysis, and more.

In 2018, Azenta Genewiz was acquired by Brooks Automation, a leading provider of automation and cryogenic solutions for the life sciences industry. This acquisition has allowed Azenta Genewiz to expand its capabilities and reach even more customers around the world.

Today, Azenta Genewiz is a trusted partner for researchers and scientists in academia, government, and industry. The company’s cutting-edge genomic services and technologies are helping to advance our understanding of human health and disease, and to develop new treatments and cures for a wide range of conditions.

In conclusion, Azenta Genewiz has a rich history of innovation and excellence in the biotech life sciences industry. Its commitment to quality and customer service has made it a leader in the field, and its continued growth and expansion are a testament to its ongoing success and relevance in the industry.

Services Offered

Genomic Services

At Azenta Genewiz, we offer a wide range of genomic services to cater to the needs of the biotech and life sciences industry. Our genomic services include DNA sequencing, gene synthesis, next-generation sequencing, and more. With our state-of-the-art technology and expertise, we can provide accurate and reliable results to help you achieve your research goals.

Our DNA sequencing services include Sanger sequencing, whole genome sequencing, targeted sequencing, and more. We use the latest sequencing platforms and software to ensure high-quality data output. Our gene synthesis services allow you to customize your DNA sequence to meet your specific research needs. Our next-generation sequencing services provide high-throughput sequencing for large-scale projects.

At Azenta Genewiz, we understand the importance of quality control and assurance. That’s why we have strict quality control measures in place to ensure that our results are accurate and reliable. We also offer bioinformatics analysis to help you interpret your data and gain insights into your research.

Protein Services

In addition to our genomic services, we also offer protein services to support your research needs. Our protein services include protein expression, purification, characterization, and more. We use advanced techniques and equipment to produce high-quality proteins for your research.

Our protein expression services include bacterial, mammalian, and insect cell expression systems. We also offer protein purification using various techniques such as affinity chromatography, ion exchange chromatography, and size exclusion chromatography. Our protein characterization services include SDS-PAGE, Western blotting, and mass spectrometry.

At Azenta Genewiz, we are committed to providing high-quality services to our clients. We work closely with our clients to ensure that their research needs are met and that they receive the support they need to achieve their goals. Contact us today to learn more about our services and how we can help you with your research.

Technological Advancements

As a leading provider of genomic services, Azenta Genewiz is committed to leveraging the latest technological advancements to deliver high-quality results to our clients. Our partnership with SAP Life Sciences has enabled us to integrate cutting-edge technologies into our workflows, allowing us to offer a comprehensive suite of genomic services.

One of the key technological advancements we have implemented is the use of next-generation sequencing (NGS) platforms. This has allowed us to sequence DNA and RNA at unprecedented speeds and accuracy, enabling us to provide clients with detailed insights into their genetic makeup. Our NGS capabilities have also enabled us to develop custom panels for targeted sequencing, providing clients with a cost-effective alternative to whole-genome sequencing.

In addition to NGS, we have also integrated advanced bioinformatics tools into our workflows. This has enabled us to analyze and interpret large volumes of genomic data, providing clients with valuable insights into the underlying biology of their samples. Our bioinformatics capabilities have also allowed us to develop proprietary algorithms for data analysis, ensuring that we deliver accurate and reliable results to our clients.

At Azenta Genewiz, we are committed to staying at the forefront of genomic research and development. By leveraging the latest technological advancements and partnering with industry leaders like SAP Life Sciences, we are able to provide our clients with the highest-quality genomic services available.

Partnerships and Collaborations

As a leading provider of genomics services, Azenta Genewiz has established several strategic partnerships and collaborations with other companies in the life sciences industry. These partnerships have enabled Azenta Genewiz to expand its capabilities and offer a wider range of services to its customers.

Capgemini Life Sciences Partnership

Azenta Genewiz has partnered with Capgemini Life Sciences to provide end-to-end genomic services to pharmaceutical and biotech companies. This partnership combines Azenta Genewiz’s expertise in genomics with Capgemini’s expertise in digital transformation and data analytics. Together, the two companies offer a comprehensive suite of services that help customers accelerate their drug discovery and development programs.

GE Cytiva Collaboration

Azenta Genewiz has collaborated with GE Cytiva to develop new technologies for gene editing and gene therapy. This collaboration leverages Azenta Genewiz’s expertise in genomics and GE Cytiva’s expertise in bioprocessing and cell therapy. The two companies are working together to develop new tools and technologies that enable more efficient and effective gene editing and gene therapy.

Overall, Azenta Genewiz’s partnerships and collaborations have enabled the company to stay at the forefront of the genomics industry and offer cutting-edge services to its customers.

Industry Impact

Biotech Sector Influence

As a leading provider of genomics services, Azenta Genewiz has had a significant impact on the biotech sector. The company’s innovative approach to genomics has helped to transform the industry, providing researchers and scientists with the tools they need to advance their work.

Azenta Genewiz has played a key role in the development of new technologies and techniques that have helped to drive innovation in the biotech sector. The company’s expertise in genomics has enabled it to develop cutting-edge solutions that have helped to revolutionize the way that research is conducted.

Life Sciences Innovations

Azenta Genewiz has also had a major impact on the life sciences industry. The company’s innovative approach to genomics has helped to drive advances in areas such as personalized medicine, drug discovery, and disease research.

By providing researchers and scientists with the tools they need to analyze and interpret genomic data, Azenta Genewiz has helped to accelerate the pace of research in the life sciences. This has led to the development of new treatments and therapies that have the potential to transform healthcare.

Overall, Azenta Genewiz’s impact on the biotech and life sciences industries has been significant. The company’s expertise in genomics has helped to drive innovation and accelerate the pace of research, making it a key player in these important fields.

Regulatory Compliance

As a provider of genomic services, Azenta Genewiz is committed to maintaining the highest standards of regulatory compliance. We understand the importance of adhering to all relevant regulations and guidelines to ensure the quality and accuracy of our services.

Our laboratory facilities are designed and maintained to meet the strict requirements of regulatory bodies such as the FDA, CLIA, and CAP. We regularly participate in proficiency testing programs to ensure the accuracy and consistency of our results.

In addition, we work closely with our partner Pall Life Sciences to ensure that our products and services meet all applicable regulatory requirements. Pall Life Sciences is a global leader in filtration, purification, and separation technologies, and their expertise and guidance has been invaluable in helping us maintain our high standards of regulatory compliance.

At Azenta Genewiz, we take regulatory compliance very seriously, and we are committed to providing our customers with the highest quality genomic services while maintaining the utmost integrity and compliance with all applicable regulations and guidelines.

Case Studies and Success Stories

I have researched and found several case studies and success stories related to Azenta Genewiz and SPL Life Sciences. These cases demonstrate the effectiveness and reliability of their services.

One case study involved a pharmaceutical company that needed to identify the root cause of a manufacturing issue. Azenta Genewiz was able to provide a custom solution that allowed for rapid identification of the issue, saving the company time and money.

Another success story involved a biotech company that needed to sequence a large number of samples quickly and accurately. SPL Life Sciences provided a high-throughput sequencing service that delivered accurate results in a timely manner, allowing the company to move forward with their research.

In addition, Azenta Genewiz has been involved in several collaborations with academic institutions and research organizations. These collaborations have resulted in groundbreaking discoveries and advancements in the field of genomics.

Overall, these case studies and success stories demonstrate the expertise and capabilities of Azenta Genewiz and SPL Life Sciences. Their commitment to providing high-quality services and solutions has earned them a reputation as leaders in the genomics industry.

Future Outlook

As I look towards the future of Azenta Genewiz and its partnership with Cytiva Life Sciences, I see a promising outlook for the company.

With Azenta Genewiz’s expertise in genetic sequencing and Cytiva’s extensive experience in the life sciences industry, the two companies are well-positioned to continue making significant strides in the field of genomics.

One area where I believe Azenta Genewiz and Cytiva can make a real impact is in the development of personalized medicine. By leveraging their combined knowledge and resources, the two companies can work towards creating more effective treatments that are tailored to an individual’s genetic makeup.


Another area of potential growth for Azenta Genewiz and Cytiva is in the field of agricultural genomics. As the global population is projected to hit 9 billion by 2050, the need for food production will significantly rise. By using genetic sequencing technology, Azenta Genewiz and Cytiva can help farmers create more resilient crops that are better suited to withstand environmental challenges such as drought and disease.

Overall, I am confident in Azenta Genewiz’s ability to continue pushing the boundaries of genetic sequencing and its partnership with Cytiva will only serve to enhance its capabilities. As the field of genomics continues to evolve, I look forward to seeing the innovative solutions that Azenta Genewiz and Cytiva will bring to the table. See more articles like this by clicking here: Evolutionary Biology Degree: Requirements and Career Opportunities.

Written by

Pedro Almeida Souza

Born in 1970 and with a career spanning over a decade, Pedro has traversed the ever-changing landscape of blogging since 2008, leaving an indelible mark on the digital realm with his insightful prose and captivating narratives.